BeStock  
Markets › Compare › AAPG vs TSHA

AAPG vs TSHA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
AAPG · Ascentage Pharma$11.97 ▼ 3.78%
TSHA · Taysha Gene Therapies$3.72 ▼ 1.33%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

306498131165Nov 24, '25May 26, '26Nov 20, '26
  • AAPG -62.6%
  • TSHA -15.8%

Head to head

MetricAAPGTSHA
Price$11.97$3.72
Change today▼ 3.78%▼ 1.33%
Market cap$1.12B$1.21B
Return, 3 months-28.4%-37.7%
Return, year to date-54.4%-32.4%
Return, 1 year-60.9%-11.2%
P/E (TTM)––
P/B13.43.4
P/E percentile vs own 5y98th22nd
Dividend yield––
Revenue growth (YoY, latest qtr)-41.5%-100.0%
Net profit growth (YoY)-206.4%-73.5%
Gross margin93.9%–
Operating margin-216.7%-2,854.9%
Net margin-228.5%-2,728.0%
Return on equity-240.3%-47.1%
Analyst target vs. price+250.9%+285.2%
Analyst buy share100%100%
RSI (14)2935
30-day volatility64.7%74.4%
Max drawdown, 1 year-65.1%-49.7%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • TSHA is the largest of the group by market value.
  • TSHA has returned the most over the past year.
  • AAPG is growing revenue fastest.
  • AAPG keeps the most profit per dollar of sales.
  • AAPG has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top